Underprescribing of Clozapine and Unexplained Variation in Use across Hospitals and Regions in the Canadian Province of Québec

Latimer, Eric; Wynant, Willy; Clark, Robin; Malla, Ashok; Moodie, Erica; Tamblyn, Robyn; Naidu, Adonia
April 2013
Clinical Schizophrenia & Related Psychoses;Apr2013, Vol. 7 Issue 1, p33
Academic Journal
Background: Clozapine remains the antipsychotic of choice for people who, having met the criteria for a diagnosis of schizophrenia or a related psychotic disorder, do not respond adequately to other antipsychotic medications. Utilization rates appear highly variable across jurisdictions, with an overall tendency toward underuse. This paper describes patterns of clozapine use in the province of Québec, Canada. Methods: Individuals with a diagnosis of schizophrenia were identified using linked government medical claims and hospitalization records for 2003 and 2004. Linked data on their filled prescriptions in 2004 were then used to determine clozapine-use rates at the level of the province, the region, and the hospital at which individuals received most of their services. Individual predictors of clozapine use were identified using logistic regression. Results: Only 6.7% of the 29,155 individuals identified with schizophrenia received clozapine for six months or longer in 2004. Utilization rates ranged from 3.9 to 9.0% among regions with 1,000 or more people with schizophrenia. Over 8% of 61 hospitals did not prescribe clozapine at all. People with schizophrenia taking clozapine experienced 3.4 fewer days of hospitalization per year than those not taking clozapine-representing a cost offset of about $1,800 per year. Medication costs were higher, however, by about $3,000 per year. Conclusions: Given the increasingly clear benefits of clozapine for people who do not respond to other antipsychotics, measures to increase access to clozapine for people who can benefit from it are likely to be cost effective and are urgently needed.


Related Articles

  • Dynamic in Prescribing Antipsychotic Drugs during Five Year Period (2001-2005) in the Psychiatric Hospital »Vrapče«, Zagreb, Croatia. Jukić, Vlado; Herceg, Miroslav; Brečić, Petrana; Vidović, Domagoj; Križaj, Aida // Collegium Antropologicum;Jan2008 Supplement 1, Vol. 32, p211 

    Aim of this study was to determine changes in prescribing antipsychotics during 5 year period in Psychiatric Hospital Vrapče. Data about type of antipsychotic medication, ward and gender were collected for all patients receiving antipsychotics on 1st of October. During 5 year period decrease...

  • Use of Clozapine for the Treatment of Schizophrenia: Findings of the 2006 Research on the China Psychotropic Prescription Studies. Tian-Mei Si; Yun-shu Zhang; Liang Shu; Ke-Qing Li; Xie-He Liu; Qi-Yi Mei; Gao-Hua Wang; Pei-Shen Bai; Li-Ping Ji; Xian-Sheng Cheng; Cui Ma; Jian-Guo Shi; Hong-Yan Zhang; Hong Ma; Xin Yu // Clinical Psychopharmacology & Neuroscience;Aug2012, Vol. 10 Issue 2, p99 

    Objective: Clozapine is one of the most commonly used antipsychotic drugs in China, To date, few studies have investigated the patterns the prescription of clozapine nationwide. The present study examined these patterns in China in 2006 and identified the demographic and clinical characteristics...

  • Conventional antipsychotic treatments. Morris, David // GP: General Practitioner;1/28/2002, p59 

    Offers tips on the prescription of neuroleptic drugs. Definition of conventional antipsychotic; Effectiveness in treating acute psychotic states; Use in the maintenance of treatment of psychoses.

  • Antipsychotics dosage and antiparkinsonian prescriptions. Acquaviva, Eric; Gasquet, Isabelle; Falissard, Bruno // Clinical Practice & Epidemiology in Mental Health;2007, Vol. 3, p14 

    Background: To study the link between the dosage of several antipsychotics and the prescription of antiparkinsonians in an observational study. Methods: In the context of a national naturalistic prospective observational study, a database containing all the prescriptions from 100 French...

  • Clozapine and co-prescribed psychotropics: a short report. Gupta, Maneesh // Clinical Practice & Epidemiology in Mental Health;2008, Vol. 4, Special section p1 

    Clozapine is the drug of choice in treatment resistant schizophrenia. It reduces hospitalizations. Patients on clozapine are often co-prescribed other psychotropics. This report looks at a sample of twenty patients on clozapine. It finds that almost two thirds were on a psychotropic along with...

  • Clozapine-Associated Neuroleptic Malignant Syndrome Followed by Catatonia: A Case Report. EROL, Almıla; PUTGÜL, Gülperi; SERT, Engin; METE, Levent // Turkish Journal of Psychiatry;2013, Vol. 24 Issue 2, p1 

    Objective: Neuroleptic malignant syndrome (NMS) is a rare life-threatening condition associated with the use of antipsychotics and other drugs that influence dopaminergic transmission. Although NMS is typically associated with classical antipsychotics, it can also be induced by atypical...

  • An indicator of appropriate neuroleptic prescribing in nursing homes. Alice Oborne, C.; Hooper, Richard; K. A. Chi Li; G. Swift, Cameron; H. D. Jackson, Stephen // Age & Ageing;Nov2002, Vol. 31 Issue 6, p435 

    Presents a study which assessed the appropriateness of neuroleptic prescribing in nursing homes. Criteria of appropriate prescribing from Omnibus Reconciliation Act 1990; Data analysis of nursing homes and their attending general practices; Determinants of appropriate prescribing.

  • Outpatient antipsychotic prescribing varied in NZ.  // PharmacoEconomics & Outcomes News;5/22/2004, Issue 453, p7 

    Presents the results of a study regarding the variation in the prescribing of antipsychotics for outpatients across different health sectors in Auckland, New Zealand. Method used to assess antipsychotic usage among the population of community mental health services in Auckland; Proportion of...

  • The use of atypical antipsychotic drugs. Morris, David // GP: General Practitioner;2/4/2002, p62 

    Focuses on the use of atypical antipsychotic drugs in Great Britain. Prescription as first-line antipsychotics by psychiatrists; Details of the prototype molecule clozapine; Side effects of the drug.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics